While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

FRANKFURT, Germany, May 29, 2025 /CNW/ -- Qualifyze, already the global leader in third-party audit services for the ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...

A final dividend and a number of strategic initiatives were highlighted by Hyderabad-based pharmaceutical company Sigachi ...

Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs ...

Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

Global private equity and venture capital investments in pharmaceutical companies lag 2024 figures, and regulatory headwinds ...

As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...

The venture will utilize advanced pharmaceutical manufacturing technologies, including syrups, tablets, prefilled syringes, ...

Vertex has built its earnings thanks to its CF program, and with a new CF drug approved a few months ago, the company may be ...